Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats

Archives of Pharmacal Research

Volumn 34, Issue 5, 2011, Pages 847-852

  Kim, Chan Sik ^a,b   Kim, Junghyun ^a   Lee, Yun Mi ^a   Sohn, Eunjin ^a   Jo, Kyuhyung ^a   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Aldose reductase; Chlorogenic acid; Sugar cataract

Indexed keywords

ALDEHYDE REDUCTASE; CHLOROGENIC ACID; GALACTOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATARACT; CATARACTOGENESIS; CELL SWELLING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; LENS EPITHELIUM; LENS FIBER; MALE; MEMBRANE RUPTURE; NONHUMAN; RAT;

ALDEHYDE REDUCTASE; ANIMALS; CATARACT; CELL MEMBRANE; CHLOROGENIC ACID; DIABETES COMPLICATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPITHELIAL CELLS; EYE PROTEINS; GALACTOSE; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; LENS CORTEX, CRYSTALLINE; LENS, CRYSTALLINE; MALE; MICROSCOPY, FLUORESCENCE; QUINIC ACID; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79960263041     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0519-z     Document Type: Article

References (30)

1. Y. Akagi P. F. Kador J. H. Kinoshita 1987 Immunohistochemical localization for aldose reductase in diabetic lenses Invest. Ophthalmol. Vis. Sci. 28 163 167 3100473 1:CAS:528:DyaL2sXkt1Wnuro%3D (Pubitemid 17230205)
2. A. Andrade-Cetto H. Wiedenfeld 2001 Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats J. Ethnopharmacol. 78 145 149 11694359 10.1016/S0378-8741(01)00335-X 1:CAS:528:DC%2BD3MXnvFClur4%3D (Pubitemid 32994783)
3. S. Ao Y. Shingu C. Kikuchi Y. Takano K. Nomura T. Fujiwara Y. Ohkubo Y. Notsu I. Yamaguchi 1991 Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat Metabolism 40 77 87 1898618 10.1016/0026-0495(91)90196-4 1:CAS:528: DyaK3MXhtlGqsrc%3D
4. L. Costantino G. Rastelli P. Vianello G. Cignarella D. Barlocco 1999 Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches Med. Res. Rev. 19 3 23 9918192 10.1002/(SICI)1098-1128(199901)19:1<3::AID-MED2>3.0.CO;2-7 1:CAS:528:DyaK1MXjs1ygtA%3D%3D (Pubitemid 29006576)
5. W. Harries J. Tsui N. J. Unakar 1985 Ultrastructural cytochemistry: effect of Sorbinil on arylsulfatases in cataractous lenses Curr. Eye Res. 4 657 666 4028788 10.3109/02713688509017659 1:CAS:528:DyaL2MXkslShurg%3D (Pubitemid 15071015)
6. A. Herrera-Arellano L. Aguilar-Santamaría B. García- Hernández P. Nicasio-Torres J. Tortoriello 2004 Clinical trial of Cecropia obtusifolia and Marrubium vulgare leaf extracts on blood glucose and serum lipids in type 2 diabetics Phytomedicine 11 561 566 15636168 10.1016/j.phymed.2004.01.006 1:STN:280:DC%2BD2M%2FhtVCqtg%3D%3D (Pubitemid 40007737)
7. R. Huang F. Shi T. Lei Y. Song C. L. Hughes G. Liu 2007 Effect of the isoflavone genistein against galactoseinduced cataracts in rats Exp. Biol. Med. 232 118 125 1:CAS:528:DC%2BD2sXmslejtA%3D%3D (Pubitemid 46089946)
8. H. A. Jung M. D. Islam Y. S. Kwon S. E. Jin Y. K. Son J. J. Park H. S. Sohn J. S. Choi 2011 Extraction and identification of three major aldose reductase inhibitors from Artemisia montana Food Chem. Toxicol. 49 376 384 21092751 10.1016/j.fct.2010.11.012 1:CAS:528:DC%2BC3MXhtlKltr0%3D
9. P. F. Kador J. Inoue E. F. Secchi M. J. Lizak L. Rodriguez K. Mori W. Greentree K. Blessing P. A. Lackner S. Sato 1998 Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats Exp. Eye Res. 67 203 208 9733586 10.1006/exer.1998.0502 1:CAS:528:DyaK1cXmt1Kntb8%3D (Pubitemid 28428268)
10. Y. S. Kim N. H. Kim D. H. Jung D. S. Jang Y. M. Lee J. M. Kim J. S. Kim 2008 Genistein inhibits aldose reductase activity and high glucose-induced TGF-beta2 expression in human lens epithelial cells Eur. J. Pharmacol. 594 18 25 18692043 10.1016/j.ejphar.2008.07.033 1:CAS:528:DC%2BD1cXhtVynurrI
11. J. H. Kinoshita 1974 Mechanisms initiating cataract formation. Proctor Lecture Invest. Ophthalmol. 13 713 724 4278188 1:CAS:528:DyaE2MXivFaqsw%3D%3D
12. J. H. Kinoshita P. Kador M. Catiles 1981 Aldose reductase in diabetic cataracts JAMA 246 257 261 6787220 10.1001/jama.246.3.257 1:CAS:528: DyaL3MXkslOqtb4%3D (Pubitemid 11074896)
13. Y. Kono S. Kashine T. Yoneyama Y. Sakamoto Y. Matsui H. Shibata 1998 Iron chelation by chlorogenic acid as a natural antioxidant Biosci. Biotechnol. Biochem. 62 22 27 9501514 10.1271/bbb.62.22 1:CAS:528:DyaK1cXpsVCksA%3D%3D (Pubitemid 128475017)
14. A. Y. Lee S. K. Chung S. S. Chung 1995 Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens Proc. Natl. Acad. Sci. U. S. A. 92 2780 2784 7708723 10.1073/pnas.92.7.2780 1:CAS:528:DyaK2MXksl2rtr8%3D
15. G. Liu G. E. Hale C. L. Hughes 2000 Galactose metabolism and ovarian toxicity Reprod. Toxicol. 14 377 384 11020650 10.1016/S0890-6238(00)00096-4 1:CAS:528:DC%2BD3cXntVWgsbg%3D
16. M. F. Lou J. E. Dickerson Jr. R. Garadi B. M. York Jr. 1988 Glutathione depletion in the lens of galactosemic and diabetic rats Exp. Eye Res. 46 517 530 3133235 10.1016/S0014-4835(88)80009-5 1:CAS:528:DyaL1cXkt1Wit7o%3D
17. T. Matsui Y. Nakamura H. Ishikawa A. Matsuura F. Kobayashi 1994 Pharmacological profiles of a novel aldose reductase inhibitor, SPR-210, and its effects on streptozotocin-induced diabetic rats Jpn. J. Pharmacol. 64 115 124 8028228 10.1254/jjp.64.115 1:CAS:528:DyaK2cXjtFGmt7k%3D (Pubitemid 24091839)
18. I. Miwa M. Kanbara H. Wakazono J. Okuda 1988 Analysis of sorbitol, galactitol, and myo-inositol in lens and sciatic nerve by high-performance liquid chromatography Anal. Biochem. 173 39 44 3189800 10.1016/0003-2697(88) 90155-8 1:CAS:528:DyaL1cXlsVGmtLw%3D
19. K. Mizuno N. Kato A. Matsubara K. Nakano M. Kurono 1992 Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2′,5′- dioxospiro[chroman-4,4′-imidazolidine]-2-carboxamide (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats Metabolism 41 1081 1086 1328819 10.1016/0026-0495(92)90289-M 1:CAS:528:DyaK38Xmt1Kju74%3D
20. N. Nakai Y. Fujii K. Kobashi K. Nomura 1985 Aldose reductase inhibitors: flavonoids, alkaloids, acetophenones, benzophenones, and spirohydantoins of chroman Arch. Biochem. Biophys. 239 491 496 2988452 10.1016/0003-9861(85)90717-9 1:CAS:528:DyaL2MXktlCjsrY%3D (Pubitemid 15013763)
21. P. J. Oates B. L. Mylari 1999 Aldose reductase inhibitors: therapeutic implications for diabetic complications Expert Opin. Investig. Drugs 8 2095 2119 11139842 10.1517/13543784.8.12.2095 1:CAS:528:DyaK1MXns1eisLg%3D
22. I. G. Obrosova M. J. Stevens H. J. Lang 2001 Diabetesinduced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy Pharmacology 62 172 180 11287819 10.1159/000056091 1:CAS:528:DC%2BD3MXjt1WltLo%3D (Pubitemid 32260858)
23. J. W. Patterson K. W. Bunting 1966 Sugar cataracts, polyol levels and lens swelling Doc. Ophthalmol. 20 64 72 5982290 10.1007/BF00165406 1:STN:280:DyaF1c%2FgtVektQ%3D%3D
24. V. N. Reddy D. Schwass B. Chakrapani C. P. Lim 1976 Biochemical changes associated with the development and reversal of galactose cataracts Exp. Eye Res. 23 483 493 1001376 10.1016/0014-4835(76)90157-3 1:CAS:528: DyaE2sXhsVylsw%3D%3D
25. D. V. Rodriguez de Sotillo M. Hadley 2002 Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats J. Nutr. Biochem. 13 717 726 12550056 10.1016/S0955-2863(02)00231-0 1:CAS:528:DC%2BD38XpsFWitLk%3D (Pubitemid 35463200)
26. N. Simard-Duquesne E. Greselin J. Dubuc D. Dvornik 1985 The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats Metabolism 34 885 892 3930915 10.1016/0026-0495(85)90133-7 1:CAS:528: DyaL2MXlsFers78%3D (Pubitemid 15234464)
27. H. Terashima K. Hama R. Yamamoto M. Tsuboshima R. Kikkawa I. Hatanaka Y. Shigeta 1984 Effects of a new aldose reductase inhibitor on various tissues in vitro J. Pharmacol. Exp. Ther. 229 226 230 6423811 1:CAS:528:DyaL2cXktVSnuro%3D (Pubitemid 14082937)
28. D. R. Tomlinson E. J. Stevens L. T. Diemel 1994 Aldose reductase inhibitors and their potential for the treatment of diabetic complications Trends Pharmacol. Sci. 15 293 297 7940997 10.1016/0165-6147(94)90010-8 1:CAS:528:DyaK2cXmt1SrsLw%3D (Pubitemid 24245679)
29. N. J. Unakar J. Y. Tsui 1983 Inhibition of galactose-induced alterations in ocular lens with sorbinil Exp. Eye Res. 36 685 694 6303825 10.1016/0014-4835(83)90106-9 1:CAS:528:DyaL3sXktleisrk%3D (Pubitemid 13057413)
30. N. J. Unakar W. Harries J. Tsui 1985 Acid phosphatase II. Cytochemical localization in lenses of normal and galactose-fed rats Exp. Eye Res. 40 117 126 3920063 10.1016/0014-4835(85)90114-9 1:CAS:528:DyaL2MXhsVOjsb4%3D (Pubitemid 15133249)